Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Hisamitsu Pharmaceutical Co ( (JP:4530) ) is now available.
Hisamitsu Pharmaceutical Co., Inc. announced a slate of candidates for its board of directors, to be voted on at the upcoming annual general meeting in May 2025. The announcement includes the reappointment of several current directors and the introduction of new candidates, reflecting the company’s strategic direction and governance priorities.
More about Hisamitsu Pharmaceutical Co
Hisamitsu Pharmaceutical Co., Inc. operates in the pharmaceutical industry, focusing on the development and production of medical products. The company is known for its transdermal therapeutic systems and has a significant presence in the healthcare market.
YTD Price Performance: 3.33%
Average Trading Volume: 100
Technical Sentiment Signal: Strong Buy
Current Market Cap: $2.06B
For detailed information about 4530 stock, go to TipRanks’ Stock Analysis page.